-
2
-
-
78650491562
-
Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics
-
Allen KE, Weiss GJ. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther. 2010;9:3126-36.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 3126-3136
-
-
Allen, K.E.1
Weiss, G.J.2
-
3
-
-
70349826431
-
Understanding the causes of multidrug resistance in cancer: A comparison of doxorubicin and sunitinib
-
Broxterman HJ, Gotink KJ, Verheul HM. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug Resist Updat. 2009;12:114-26.
-
(2009)
Drug Resist Updat
, vol.12
, pp. 114-126
-
-
Broxterman, H.J.1
Gotink, K.J.2
Verheul, H.M.3
-
4
-
-
84865243290
-
EGF receptor-targeted therapy in non-small-cell lung cancer: Role of germline polymorphisms in outcome and toxicity
-
Galvani E, Peters GJ, Giovannetti E. EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity. Future Oncol. 2012;8:1015-29.
-
(2012)
Future Oncol
, vol.8
, pp. 1015-1029
-
-
Galvani, E.1
Peters, G.J.2
Giovannetti, E.3
-
5
-
-
34247391483
-
Multiple paths to a drug resistance phenotype: Mutations, translocations, deletions and amplification of coding genes or promoter promoter regions, epigenetic changes and microRNAs
-
Fojo T. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter promoter regions, epigenetic changes and microRNAs. Drug Resist Updat. 2007;10:59-67.
-
(2007)
Drug Resist Updat
, vol.10
, pp. 59-67
-
-
Fojo, T.1
-
6
-
-
3042767202
-
microRNAs. small RNAs with a big role in gene regulation
-
He L, Hannon GJ. microRNAs. small RNAs with a big role in gene regulation. Nature. 2004;5:522-31.
-
(2004)
Nature
, vol.5
, pp. 522-531
-
-
He, L.1
Hannon, G.J.2
-
7
-
-
36649025655
-
OncomiRs: The discovery and progress of microRNAs in cancers
-
Cho WC. OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60-7.
-
(2007)
Mol Cancer
, vol.6
, pp. 60-67
-
-
Cho, W.C.1
-
8
-
-
33645294070
-
Oncomirs: MicroRNAs with a role in cancer
-
Esquela-Kerscher A, Slack FJ. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-69.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
9
-
-
77956501846
-
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21
-
Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18:282-93.
-
(2010)
Cancer Cell
, vol.18
, pp. 282-293
-
-
Hatley, M.E.1
Patrick, D.M.2
Garcia, M.R.3
Richardson, J.A.4
Bassel-Duby, R.5
van Rooij, E.6
Olson, E.N.7
-
10
-
-
4644310115
-
Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis
-
Pillai RS, Artus CG, Filipowicz W. Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. RNA. 2004;10:1518-25.
-
(2004)
RNA
, vol.10
, pp. 1518-1525
-
-
Pillai, R.S.1
Artus, C.G.2
Filipowicz, W.3
-
12
-
-
70349320158
-
Causes and consequences of microRNA dysregulation in cancer
-
Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704-14.
-
(2009)
Nat Rev Genet
, vol.10
, pp. 704-714
-
-
Croce, C.M.1
-
13
-
-
67749110399
-
MiRNA21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
-
Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC. MiRNA21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A. 2009;106:12085-90.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 12085-12090
-
-
Seike, M.1
Goto, A.2
Okano, T.3
Bowman, E.D.4
Schetter, A.J.5
Horikawa, I.6
Mathe, E.A.7
Jen, J.8
Yang, P.9
Sugimura, H.10
Gemma, A.11
Kudoh, S.12
Croce, C.M.13
Harris, C.C.14
-
14
-
-
34247593034
-
Impaired microRNA processing enhances cellular transformation and tumorigenesis
-
Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673-7.
-
(2007)
Nat Genet
, vol.39
, pp. 673-677
-
-
Kumar, M.S.1
Lu, J.2
Mercer, K.L.3
Golub, T.R.4
Jacks, T.5
-
15
-
-
58049213696
-
Dicer, Drosha, and outcomes in patients with ovarian cancer
-
Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008;359:2641-50.
-
(2008)
N Engl J Med
, vol.359
, pp. 2641-2650
-
-
Merritt, W.M.1
Lin, Y.G.2
Han, L.Y.3
Kamat, A.A.4
Spannuth, W.A.5
Schmandt, R.6
Urbauer, D.7
Pennacchio, L.A.8
Cheng, J.F.9
Nick, A.M.10
Deavers, M.T.11
Mourad-Zeidan, A.12
Wang, H.13
Mueller, P.14
Lenburg, M.E.15
Gray, J.W.16
Mok, S.17
Birrer, M.J.18
Lopez-Berestein, G.19
Coleman, R.L.20
Bar-Eli, M.21
Sood, A.K.22
more..
-
16
-
-
84855543629
-
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
-
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med. 2011;18:74-82.
-
(2011)
Nat Med
, vol.18
, pp. 74-82
-
-
Garofalo, M.1
Romano, G.2
Di Leva, G.3
Nuovo, G.4
Jeon, Y.J.5
Ngankeu, A.6
Sun, J.7
Lovat, F.8
Alder, H.9
Condorelli, G.10
Engelman, J.A.11
Ono, M.12
Rho, J.K.13
Cascione, L.14
Volinia, S.15
Nephew, K.P.16
Croce, C.M.17
-
17
-
-
78449268612
-
EGFR promotes lung tumorigenesis by activating miRNA7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF
-
Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW. EGFR promotes lung tumorigenesis by activating miRNA7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res. 2010;70:8822-31.
-
(2010)
Cancer Res
, vol.70
, pp. 8822-8831
-
-
Chou, Y.T.1
Lin, H.H.2
Lien, Y.C.3
Wang, Y.H.4
Hong, C.F.5
Kao, Y.R.6
Lin, S.C.7
Chang, Y.C.8
Lin, S.Y.9
Chen, S.J.10
Chen, H.C.11
Yeh, S.D.12
Wu, C.W.13
-
18
-
-
59149088381
-
The impact of microRNAs and alternative splicing in pharmacogenomics
-
Passetti F, Ferreira CG, Costa FF. The impact of microRNAs and alternative splicing in pharmacogenomics. Pharmacogenomics J. 2009;9:1-13.
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 1-13
-
-
Passetti, F.1
Ferreira, C.G.2
Costa, F.F.3
-
19
-
-
69949186250
-
Screening for epidermal growth factor receptor mutations in lung cancer
-
Spanish Lung Cancer Group
-
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sanchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M; Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009;361:958-67.
-
(2009)
N Engl J Med
, vol.361
, pp. 958-967
-
-
Rosell, R.1
Moran, T.2
Queralt, C.3
Porta, R.4
Cardenal, F.5
Camps, C.6
Majem, M.7
Lopez-Vivanco, G.8
Isla, D.9
Provencio, M.10
Insa, A.11
Massuti, B.12
Gonzalez-Larriba, J.L.13
Paz-Ares, L.14
Bover, I.15
Garcia-Campelo, R.16
Moreno, M.A.17
Catot, S.18
Rolfo, C.19
Reguart, N.20
Palmero, R.21
Sanchez, J.M.22
Bastus, R.23
Mayo, C.24
Bertran-Alamillo, J.25
Molina, M.A.26
Sanchez, J.J.27
Taron, M.28
more..
-
21
-
-
65549120766
-
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7
-
Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem. 2009;284:5731-41.
-
(2009)
J Biol Chem
, vol.284
, pp. 5731-5741
-
-
Webster, R.J.1
Giles, K.M.2
Price, K.J.3
Zhang, P.M.4
Mattick, J.S.5
Leedman, P.J.6
-
22
-
-
14844364472
-
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis
-
Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290-7.
-
(2005)
Nucleic Acids Res
, vol.33
, pp. 1290-1297
-
-
Cheng, A.M.1
Byrom, M.W.2
Shelton, J.3
Ford, L.P.4
-
23
-
-
84862787587
-
Isolation of miRNAs that target EGFR mRNA in human lung cancer
-
Yamaguchi G, Takanashi M, Tanaka M, Fujita K, Ohira T, Kuroda M, Ikeda N. Isolation of miRNAs that target EGFR mRNA in human lung cancer. Biochem Biophys Res Commun. 2012;420:411-6.
-
(2012)
Biochem Biophys Res Commun
, vol.420
, pp. 411-416
-
-
Yamaguchi, G.1
Takanashi, M.2
Tanaka, M.3
Fujita, K.4
Ohira, T.5
Kuroda, M.6
Ikeda, N.7
-
24
-
-
84867102786
-
MicroRNA-133b Inhibits the growth of non-small cell lung cancer by targeting the epidermal growth factor receptor
-
Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang R, Huang P, Yin Y, Shu Y. MicroRNA-133b Inhibits the growth of non-small cell lung cancer by targeting the epidermal growth factor receptor. FEBS J. 2012;279:3800-12.
-
(2012)
FEBS J
, vol.279
, pp. 3800-3812
-
-
Liu, L.1
Shao, X.2
Gao, W.3
Zhang, Z.4
Liu, P.5
Wang, R.6
Huang, P.7
Yin, Y.8
Shu, Y.9
-
25
-
-
65549110881
-
microRNA-205 regulates HER3 in human breast cancer
-
Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Menard S, Croce CM, Tagliabue E. microRNA-205 regulates HER3 in human breast cancer. Cancer Res. 2009;69:2195-200.
-
(2009)
Cancer Res
, vol.69
, pp. 2195-2200
-
-
Iorio, M.V.1
Casalini, P.2
Piovan, C.3
Di Leva, G.4
Merlo, A.5
Triulzi, T.6
Menard, S.7
Croce, C.M.8
Tagliabue, E.9
-
26
-
-
84865093689
-
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN
-
Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta. 2012;1822:1692-704.
-
(2012)
Biochim Biophys Acta
, vol.1822
, pp. 1692-1704
-
-
Liu, B.1
Wu, X.2
Liu, B.3
Wang, C.4
Liu, Y.5
Zhou, Q.6
Xu, K.7
-
27
-
-
77949912309
-
MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer
-
Zhong M, Ma X, Sun C, Chen L. MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer. Chem Biol Interact. 2010;184:431-8.
-
(2010)
Chem Biol Interact
, vol.184
, pp. 431-438
-
-
Zhong, M.1
Ma, X.2
Sun, C.3
Chen, L.4
-
28
-
-
73949116135
-
miRNA126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7
-
Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L. miRNA126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun. 2010;391:1483-9.
-
(2010)
Biochem Biophys Res Commun
, vol.391
, pp. 1483-1489
-
-
Sun, Y.1
Bai, Y.2
Zhang, F.3
Wang, Y.4
Guo, Y.5
Guo, L.6
-
29
-
-
48949115082
-
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines
-
Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB, Nana-Sinkam SP. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun. 2008;373:607-12.
-
(2008)
Biochem Biophys Res Commun
, vol.373
, pp. 607-612
-
-
Crawford, M.1
Brawner, E.2
Batte, K.3
Yu, L.4
Hunter, M.G.5
Otterson, G.A.6
Nuovo, G.7
Marsh, C.B.8
Nana-Sinkam, S.P.9
-
30
-
-
79959954361
-
Independent and tissue-specific prognostic impact of miRNA126 in nonsmall cell lung cancer: Coexpression with vascular endothelial growth factor-A predicts poor survival
-
Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT. Independent and tissue-specific prognostic impact of miRNA126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer. 2011;117:3193-200.
-
(2011)
Cancer
, vol.117
, pp. 3193-3200
-
-
Donnem, T.1
Lonvik, K.2
Eklo, K.3
Berg, T.4
Sorbye, S.W.5
Al-Shibli, K.6
Al-Saad, S.7
Andersen, S.8
Stenvold, H.9
Bremnes, R.M.10
Busund, L.T.11
-
31
-
-
84856247990
-
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer
-
Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, Andersen S, Stenvold H, Al-Shibli K, Al-Saad S, Bremnes RM, Busund LT. MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PLoS One. 2012;7:e29671.
-
(2012)
PLoS One
, vol.7
-
-
Donnem, T.1
Fenton, C.G.2
Lonvik, K.3
Berg, T.4
Eklo, K.5
Andersen, S.6
Stenvold, H.7
Al-Shibli, K.8
Al-Saad, S.9
Bremnes, R.M.10
Busund, L.T.11
-
33
-
-
84864865233
-
MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines
-
Wang YS, Wang YH, Xia HP, Zhou SW, Schmid-Bindert G, Zhou CC. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. Asian Pac J Cancer Prev. 2012;13:255-60.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 255-260
-
-
Wang, Y.S.1
Wang, Y.H.2
Xia, H.P.3
Zhou, S.W.4
Schmid-Bindert, G.5
Zhou, C.C.6
-
34
-
-
35649020283
-
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
-
Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007;104:15805-10.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 15805-15810
-
-
Fabbri, M.1
Garzon, R.2
Cimmino, A.3
Liu, Z.4
Zanesi, N.5
Callegari, E.6
Liu, S.7
Alder, H.8
Costinean, S.9
Fernandez-Cymering, C.10
Volinia, S.11
Guler, G.12
Morrison, C.D.13
Chan, K.K.14
Marcucci, G.15
Calin, G.A.16
Huebner, K.17
Croce, C.M.18
-
35
-
-
84855359334
-
A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
-
Bryant JL, Britson J, Balko JM, Willian M, Timmons R, Frolov A, Black EP. A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. Br J Cancer. 2012;106:148-56.
-
(2012)
Br J Cancer
, vol.106
, pp. 148-156
-
-
Bryant, J.L.1
Britson, J.2
Balko, J.M.3
Willian, M.4
Timmons, R.5
Frolov, A.6
Black, E.P.7
-
36
-
-
50849141873
-
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
-
Zucali PA, Ruiz MG, Giovannetti E, Destro A, Varella-Garcia M, Floor K, Ceresoli GL, Rodriguez JA, Garassino I, Comoglio P, Roncalli M, Santoro A, Giaccone G. Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors. Ann Oncol. 2008;19:1605-12.
-
(2008)
Ann Oncol
, vol.19
, pp. 1605-1612
-
-
Zucali, P.A.1
Ruiz, M.G.2
Giovannetti, E.3
Destro, A.4
Varella-Garcia, M.5
Floor, K.6
Ceresoli, G.L.7
Rodriguez, J.A.8
Garassino, I.9
Comoglio, P.10
Roncalli, M.11
Santoro, A.12
Giaccone, G.13
-
37
-
-
54049115558
-
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR
-
Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem. 2008;54:1696-704.
-
(2008)
Clin Chem
, vol.54
, pp. 1696-1704
-
-
Markou, A.1
Tsaroucha, E.G.2
Kaklamanis, L.3
Fotinou, M.4
Georgoulias, V.5
Lianidou, E.S.6
-
38
-
-
67651002796
-
MicroRNA classifiers for predicting prognosis of squamous cell lung cancer
-
Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 2009;69:5776-83.
-
(2009)
Cancer Res
, vol.69
, pp. 5776-5783
-
-
Raponi, M.1
Dossey, L.2
Jatkoe, T.3
Wu, X.4
Chen, G.5
Fan, H.6
Beer, D.G.7
-
39
-
-
75149130928
-
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection
-
Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res. 2010;70:36-45.
-
(2010)
Cancer Res
, vol.70
, pp. 36-45
-
-
Patnaik, S.K.1
Kannisto, E.2
Knudsen, S.3
Yendamuri, S.4
-
40
-
-
78449296222
-
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma
-
Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M, Dunant A, Pham TC, Petrini I, Lee A, Khan MA, Hainaut P, Pignon JP, Brambilla E, Popper HH, Filipits M, Harris CC, Giaccone G. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res. 2010;70:8288-98.
-
(2010)
Cancer Res
, vol.70
, pp. 8288-8298
-
-
Voortman, J.1
Goto, A.2
Mendiboure, J.3
Sohn, J.J.4
Schetter, A.J.5
Saito, M.6
Dunant, A.7
Pham, T.C.8
Petrini, I.9
Lee, A.10
Khan, M.A.11
Hainaut, P.12
Pignon, J.P.13
Brambilla, E.14
Popper, H.H.15
Filipits, M.16
Harris, C.C.17
Giaccone, G.18
-
41
-
-
44849091213
-
EGFR regulation by microRNA in lung cancer: Correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
-
Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA Jr, Haney J, Helfrich BA, Kato H, Hirsch FR, Franklin WA. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol. 2008;19:1053-9.
-
(2008)
Ann Oncol
, vol.19
, pp. 1053-1059
-
-
Weiss, G.J.1
Bemis, L.T.2
Nakajima, E.3
Sugita, M.4
Birks, D.K.5
Robinson, W.A.6
Varella-Garcia, M.7
Bunn Jr., P.A.8
Haney, J.9
Helfrich, B.A.10
Kato, H.11
Hirsch, F.R.12
Franklin, W.A.13
-
42
-
-
84856225885
-
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
-
Giovannetti E, Erozenci A, Smit J, Danesi R, Peters GJ. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Crit Rev Oncol Hematol. 2012;81:103-22.
-
(2012)
Crit Rev Oncol Hematol
, vol.81
, pp. 103-122
-
-
Giovannetti, E.1
Erozenci, A.2
Smit, J.3
Danesi, R.4
Peters, G.J.5
-
43
-
-
80052707802
-
Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer
-
Funel N, Giovannetti E, Pollina LE, del Chiaro M, Mosca F, Boggi U, Campani D. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer. Expert Rev Mol Diagn. 2011;11:695-701.
-
(2011)
Expert Rev Mol Diagn
, vol.11
, pp. 695-6701
-
-
Funel, N.1
Giovannetti, E.2
Pollina, L.E.3
del Chiaro, M.4
Mosca, F.5
Boggi, U.6
Campani, D.7
-
44
-
-
77950498821
-
Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer
-
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28:1721-6.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1721-1726
-
-
Hu, Z.1
Chen, X.2
Zhao, Y.3
Tian, T.4
Jin, G.5
Shu, Y.6
Chen, Y.7
Xu, L.8
Zen, K.9
Zhang, C.10
Shen, H.11
-
46
-
-
42249090353
-
miRNA21 Gene expression triggered by AP-1 is sustained through feedback mechanism
-
Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K. miRNA21 Gene expression triggered by AP-1 is sustained through feedback mechanism. J Mol Biol. 2008;378,492-504.
-
(2008)
J Mol Biol
, vol.378
, pp. 492-504
-
-
Fujita, S.1
Ito, T.2
Mizutani, T.3
Minoguchi, S.4
Yamamichi, N.5
Sakurai, K.6
-
47
-
-
77953022034
-
Implication of microRNAs in drug resistance for designing novel cancer therapy
-
Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Upda. 2010;13:57-66.
-
(2010)
Drug Resist Upda
, vol.13
, pp. 57-66
-
-
Sarkar, F.H.1
Li, Y.2
Wang, Z.3
Kong, D.4
Ali, S.5
-
48
-
-
78650409847
-
Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting
-
Wu DW, Cheng YW, Wang J, Chen CY, Lee H. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res. 2010;70:10392-401.
-
(2010)
Cancer Res
, vol.70
, pp. 10392-10401
-
-
Wu, D.W.1
Cheng, Y.W.2
Wang, J.3
Chen, C.Y.4
Lee, H.5
-
49
-
-
70949104622
-
miRNA221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
-
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gonelli A, costinean S, Acunzo M, Condorelli G, Croce CM. miRNA221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 2009;16:498-509.
-
(2009)
Cancer Cell
, vol.16
, pp. 498-509
-
-
Garofalo, M.1
Di Leva, G.2
Romano, G.3
Nuovo, G.4
Suh, S.S.5
Ngankeu, A.6
Taccioli, C.7
Pichiorri, F.8
Alder, H.9
Secchiero, P.10
Gonelli, A.11
Costinean, S.12
Acunzo, M.13
Condorelli, G.14
Croce, C.M.15
-
50
-
-
80053005207
-
MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration
-
Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, Ryken T, Gotway MB, Kim S, Weiss GJ. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer. 2011;129:2621-31.
-
(2011)
Int J Cancer
, vol.129
, pp. 2621-2631
-
-
Arora, S.1
Ranade, A.R.2
Tran, N.L.3
Nasser, S.4
Sridhar, S.5
Korn, R.L.6
Ross, J.T.7
Dhruv, H.8
Foss, K.M.9
Sibenaller, Z.10
Ryken, T.11
Gotway, M.B.12
Kim, S.13
Weiss, G.J.14
-
51
-
-
79953029421
-
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2
-
Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ. MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2. J Thorac Oncol. 2011;6:671-8.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 671-678
-
-
Zhang, J.G.1
Guo, J.F.2
Liu, D.L.3
Liu, Q.4
Wang, J.J.5
-
52
-
-
77953652759
-
Hsa-miRNA125a-3p and hsa-miRNA125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells
-
Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E. Hsa-miRNA125a-3p and hsa-miRNA125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer. 2010;10:318-331.
-
(2010)
BMC Cancer
, vol.10
, pp. 318-331
-
-
Jiang, L.1
Huang, Q.2
Zhang, S.3
Zhang, Q.4
Chang, J.5
Qiu, X.6
Wang, E.7
-
53
-
-
78549269168
-
miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc
-
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A, Hu J. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res. 2010;29:151-161.
-
(2010)
J Exp Clin Cancer Res
, vol.29
, pp. 151-161
-
-
Chen, Z.1
Zeng, H.2
Guo, Y.3
Liu, P.4
Pan, H.5
Deng, A.6
Hu, J.7
-
54
-
-
79959673368
-
Regulation of Axl receptor tyrosine kinase expression by miRNA34a and miRNA199a/b in solid cancer
-
Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H. Regulation of Axl receptor tyrosine kinase expression by miRNA34a and miRNA199a/b in solid cancer. Oncogene. 2011;30:2888-99.
-
(2011)
Oncogene
, vol.30
, pp. 2888-2899
-
-
Mudduluru, G.1
Ceppi, P.2
Kumarswamy, R.3
Scagliotti, G.V.4
Papotti, M.5
Allgayer, H.6
-
55
-
-
79952331586
-
DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer
-
Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F, Lu N, Sun Y, Sun J, Sun N, He J. DNA hypermethylation of microRNA-34b/c has prognostic value for stage I non-small cell lung cancer. Cancer Biol Ther. 2011;11:490-6
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 490-496
-
-
Wang, Z.1
Chen, Z.2
Gao, Y.3
Li, N.4
Li, B.5
Tan, F.6
Lu, N.7
Sun, Y.8
Sun, J.9
Sun, N.10
He, J.11
|